Related Experiment Videos
Successful use of sacral neuromodulation after failed bladder augmentation
Nathan T Rasmussen1, Michael L Guralnick, R Corey O'Connor
1Department of Urology, Medical College of Wisconsin, Milwaukee, WI.
Summary
Sacral neuromodulation offers a new treatment option for overactive bladder (OAB) patients who have not responded to bladder augmentation surgery. This minimally invasive therapy shows promise for refractory OAB cases previously considered untreatable.
Area of Science:
- Urology
- Neurosurgery
- Minimally Invasive Therapies
Background:
- Sacral neuromodulation is a standard treatment for refractory urinary urge/frequency and urge incontinence.
- Augmentation cystoplasty was a prior standard for refractory overactive bladder (OAB).
- Limited data exists on sacral neuromodulation use after bladder augmentation.
Purpose of the Study:
- To report the feasibility and outcomes of sacral neuromodulation in patients with refractory overactive bladder (OAB) following augmentation cystoplasty.
- To investigate a novel therapeutic approach for a challenging patient population.
Main Methods:
- Two patients with overactive bladder (OAB) refractory to augmentation cystoplasty underwent sacral neuromodulation.
- Outcomes were assessed based on symptom improvement and patient-reported satisfaction.
Main Results:
- Both patients experienced successful sacral neuromodulation.
- Significant improvement in refractory overactive bladder (OAB) symptoms was observed post-procedure.
- The treatment was well-tolerated with no major complications.
Conclusions:
- Sacral neuromodulation is a viable and effective treatment option for patients with overactive bladder (OAB) refractory to augmentation cystoplasty.
- This approach expands therapeutic possibilities for complex OAB cases.
- Further research is warranted to confirm these findings in larger cohorts.